954 related articles for article (PubMed ID: 15136354)
41. Transhiatal versus transthoracic esophagectomy: complication and survival rates.
Boyle MJ; Franceschi D; Livingstone AS
Am Surg; 1999 Dec; 65(12):1137-41; discussion 1141-2. PubMed ID: 10597061
[TBL] [Abstract][Full Text] [Related]
42. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M
World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
[TBL] [Abstract][Full Text] [Related]
43. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
[TBL] [Abstract][Full Text] [Related]
44. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
45. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
46. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
[TBL] [Abstract][Full Text] [Related]
47. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival.
Berger AC; Farma J; Scott WJ; Freedman G; Weiner L; Cheng JD; Wang H; Goldberg M
J Clin Oncol; 2005 Jul; 23(19):4330-7. PubMed ID: 15781882
[TBL] [Abstract][Full Text] [Related]
48. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
49. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.
Fréchette E; Buck DA; Kaplan BJ; Chung TD; Shaw JE; Kachnic LA; Neifeld JP
J Surg Oncol; 2004 Aug; 87(2):68-74. PubMed ID: 15282698
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.
Gold DG; Miller RC; Haddock MG; Gunderson LL; Quevedo F; Donohue JH; Bhatia S; Nagorney DM
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):150-5. PubMed ID: 19297105
[TBL] [Abstract][Full Text] [Related]
51. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
Kelsen DP; Ginsberg R; Pajak TF; Sheahan DG; Gunderson L; Mortimer J; Estes N; Haller DG; Ajani J; Kocha W; Minsky BD; Roth JA
N Engl J Med; 1998 Dec; 339(27):1979-84. PubMed ID: 9869669
[TBL] [Abstract][Full Text] [Related]
52. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
53. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
[TBL] [Abstract][Full Text] [Related]
54. Retrospective review of patients with locally advanced esophageal cancer treated at the University of Pittsburgh.
Defoe SG; Pennathur A; Flickinger JC; Heron DE; Gibson MK; Luketich JD; Greenberger JS
Am J Clin Oncol; 2011 Dec; 34(6):587-92. PubMed ID: 22101387
[TBL] [Abstract][Full Text] [Related]
55. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
Fujiwara Y; Kamikonya N; Inoue T; Koishi K; Yoshikawa R; Nakao K; Yagyu R; Nishiwaki M; Fujiwara M; Kojima S; Nakagawa K; Yamamura T
Oncol Rep; 2005 Nov; 14(5):1177-82. PubMed ID: 16211282
[TBL] [Abstract][Full Text] [Related]
56. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer.
Nakamura T; Hayashi K; Ota M; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
Am J Surg; 2004 Sep; 188(3):261-6. PubMed ID: 15450831
[TBL] [Abstract][Full Text] [Related]
57. Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer.
Berger AC; Scott WJ; Freedman G; Konski A; Weiner L; Cheng JD; Goldberg M
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S16-20. PubMed ID: 16399424
[TBL] [Abstract][Full Text] [Related]
58. Ten-year survival of esophageal cancer after an en-bloc esophagectomy.
Oezcelik A; Kaiser GM; Niebel W; Sleyman C; Treckmann JW; Sotiropoulos GC; Reinhardt R; Trarbach T; Malamutmann E; Paul A
J Surg Oncol; 2012 Mar; 105(3):284-7. PubMed ID: 21953648
[TBL] [Abstract][Full Text] [Related]
59. Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: impact of increased dosage on long-term results.
de Manzoni G; Pedrazzani C; Laterza E; Pasini F; Grandinetti A; Bernini M; Ruzzenente A; Zerman G; Tomezzoli A; Cordiano C
Ann Thorac Surg; 2005 Oct; 80(4):1176-83. PubMed ID: 16181836
[TBL] [Abstract][Full Text] [Related]
60. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]